ID   TOPK_HUMAN              Reviewed;         322 AA.
AC   Q96KB5; Q9NPD9; Q9NYL7; Q9NZK6;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 3.
DT   05-OCT-2010, entry version 79.
DE   RecName: Full=Lymphokine-activated killer T-cell-originated protein kinase;
DE            EC=2.7.12.2;
DE   AltName: Full=Cancer/testis antigen 84;
DE            Short=CT84;
DE   AltName: Full=MAPKK-like protein kinase;
DE   AltName: Full=Nori-3;
DE   AltName: Full=PDZ-binding kinase;
DE   AltName: Full=Spermatogenesis-related protein kinase;
DE            Short=SPK;
DE   AltName: Full=T-LAK cell-originated protein kinase;
GN   Name=PBK; Synonyms=TOPK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, PHOSPHORYLATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Lymphoid tissue;
RX   MEDLINE=20347273; PubMed=10781613; DOI=10.1074/jbc.M909629199;
RA   Abe Y., Matsumoto S., Kito K., Ueda N.;
RT   "Cloning and expression of a novel MAPKK-like protein kinase,
RT   lymphokine-activated killer T-cell-originated protein kinase,
RT   specifically expressed in the testis and activated lymphoid cells.";
RL   J. Biol. Chem. 275:21525-21531(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION, MUTAGENESIS OF
RP   64-LEU-LEU-65; THR-320 AND VAL-322, INTERACTION WITH DLG1, AND VARIANT
RP   SER-107.
RX   PubMed=10779557; DOI=10.1073/pnas.090102397;
RA   Gaudet S., Branton D., Lue R.A.;
RT   "Characterization of PDZ-binding kinase, a mitotic kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5167-5172(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT SER-107.
RC   TISSUE=Fetal brain;
RX   MEDLINE=21272559; PubMed=11378444; DOI=10.1016/S1357-2725(01)00005-X;
RA   Zhao S., Dai J., Zhao W., Xia F., Zhou Z., Wang W., Gu S., Ying K.,
RA   Xie Y., Mao Y.;
RT   "PDZ-binding kinase participates in spermatogenesis.";
RL   Int. J. Biochem. Cell Biol. 33:631-636(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-107.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   FUNCTION, INTERACTION WITH TP53, AND MUTAGENESIS OF THR-9.
RX   PubMed=17482142; DOI=10.1016/j.bbrc.2007.04.125;
RA   Nandi A.K., Ford T., Fleksher D., Neuman B., Rapoport A.P.;
RT   "Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase,
RT   involves protein-protein interaction with tumor suppressor p53.";
RL   Biochem. Biophys. Res. Commun. 358:181-188(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-24; SER-32 AND SER-59,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-9; THR-24 AND SER-32, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-107 AND LEU-241.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates MAP kinase p38. Seems to be active only
CC       in mitosis. May also play a role in the activation of lymphoid
CC       cells. When phosphorylated, forms a complex with TP53, leading to
CC       TP53 destabilization and attenuation of G2/M checkpoint during
CC       doxorubicin-induced DNA damage.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by phosphorylation (By similarity).
CC   -!- SUBUNIT: Interacts with DLG1 and TP53.
CC   -!- INTERACTION:
CC       P10398:ARAF; NbExp=3; IntAct=EBI-536853, EBI-365961;
CC       P04637:TP53; NbExp=2; IntAct=EBI-536853, EBI-366083;
CC   -!- TISSUE SPECIFICITY: Expressed in the testis and placenta. In the
CC       testis, restrictedly expressed in outer cell layer of seminiferous
CC       tubules.
CC   -!- PTM: Phosphorylated; in a cell-cycle dependent manner at mitosis.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB027249; BAA99576.1; -; mRNA.
DR   EMBL; AB027250; BAA99577.1; -; mRNA.
DR   EMBL; AF189722; AAF69107.1; -; mRNA.
DR   EMBL; AF237709; AAF71521.1; -; mRNA.
DR   EMBL; AK027291; BAB55019.1; -; mRNA.
DR   EMBL; BC015191; AAH15191.1; -; mRNA.
DR   IPI; IPI00306708; -.
DR   RefSeq; NP_060962.2; -.
DR   UniGene; Hs.104741; -.
DR   ProteinModelPortal; Q96KB5; -.
DR   SMR; Q96KB5; 5-316, 36-320.
DR   IntAct; Q96KB5; 11.
DR   MINT; MINT-130347; -.
DR   STRING; Q96KB5; -.
DR   PhosphoSite; Q96KB5; -.
DR   PeptideAtlas; Q96KB5; -.
DR   PRIDE; Q96KB5; -.
DR   Ensembl; ENST00000301905; ENSP00000301905; ENSG00000168078.
DR   GeneID; 55872; -.
DR   KEGG; hsa:55872; -.
DR   UCSC; uc003xgi.1; human.
DR   CTD; 55872; -.
DR   GeneCards; GC08M027724; -.
DR   H-InvDB; HIX0007412; -.
DR   HGNC; HGNC:18282; PBK.
DR   HPA; HPA005753; -.
DR   MIM; 611210; gene.
DR   PharmGKB; PA134925802; -.
DR   eggNOG; prNOG04821; -.
DR   HOVERGEN; HBG056011; -.
DR   InParanoid; Q96KB5; -.
DR   OMA; GVSVYLM; -.
DR   OrthoDB; EOG9N8TQS; -.
DR   PhylomeDB; Q96KB5; -.
DR   BRENDA; 2.7.12.2; 247.
DR   NextBio; 61194; -.
DR   ArrayExpress; Q96KB5; -.
DR   Bgee; Q96KB5; -.
DR   CleanEx; HS_PBK; -.
DR   Genevestigator; Q96KB5; -.
DR   GermOnline; ENSG00000168078; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB.
DR   GO; GO:0007067; P:mitosis; NAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; NAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    322       Lymphokine-activated killer T-cell-
FT                                originated protein kinase.
FT                                /FTId=PRO_0000086763.
FT   DOMAIN       32    322       Protein kinase.
FT   NP_BIND      38     46       ATP (By similarity).
FT   REGION      320    322       PDZ-interaction.
FT   ACT_SITE    167    167       Proton acceptor (By similarity).
FT   BINDING      64     64       ATP (By similarity).
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES       9      9       Phosphothreonine.
FT   MOD_RES      24     24       Phosphothreonine.
FT   MOD_RES      32     32       Phosphoserine.
FT   MOD_RES      59     59       Phosphoserine.
FT   MOD_RES     200    200       Phosphothreonine (By similarity).
FT   VARIANT     107    107       N -> S (in dbSNP:rs3779620).
FT                                /FTId=VAR_021162.
FT   VARIANT     220    220       E -> D (in dbSNP:rs17057901).
FT                                /FTId=VAR_051676.
FT   VARIANT     241    241       M -> L (in dbSNP:rs36086402).
FT                                /FTId=VAR_041234.
FT   MUTAGEN       9      9       T->E: TP53-binding.
FT   MUTAGEN      64     65       KK->AA: Loss of activity.
FT   MUTAGEN     320    320       T->A: Decrease in the binding to DLG1.
FT   MUTAGEN     322    322       V->A: Decrease in the binding to DLG1.
FT   CONFLICT     34     34       F -> I (in Ref. 3; AAF71521).
FT   CONFLICT    169    169       K -> E (in Ref. 4; BAB55019).
FT   CONFLICT    254    254       D -> N (in Ref. 4; BAB55019).
SQ   SEQUENCE   322 AA;  36085 MW;  6BF55789BC204ABE CRC64;
     MEGISNFKTP SKLSEKKKSV LCSTPTINIP ASPFMQKLGF GTGVNVYLMK RSPRGLSHSP
     WAVKKINPIC NDHYRSVYQK RLMDEAKILK SLHHPNIVGY RAFTEANDGS LCLAMEYGGE
     KSLNDLIEER YKASQDPFPA AIILKVALNM ARGLKYLHQE KKLLHGDIKS SNVVIKGDFE
     TIKICDVGVS LPLDENMTVT DPEACYIGTE PWKPKEAVEE NGVITDKADI FAFGLTLWEM
     MTLSIPHINL SNDDDDEDKT FDESDFDDEA YYAALGTRPP INMEELDESY QKVIELFSVC
     TNEDPKDRPS AAHIVEALET DV
//
